Michael Jerman - Feb 8, 2024 Form 3 Insider Report for Telomir Pharmaceuticals, Inc. (TELO)

Role
Director
Signature
/s/ Nathen Fuentes, Attorney-in-Fact for Hugh McColl, III
Stock symbol
TELO
Transactions as of
Feb 8, 2024
Transactions value $
$0
Form type
3
Date filed
2/8/2024, 05:52 PM
Previous filing
Nov 20, 2023
Next filing
Mar 27, 2024

No securities are beneficially owned.